Venous endothelin receptor function in patients with chronic heart failure.
暂无分享,去创建一个
D. Webb | J. McMurray | M. Love | W. Haynes
[1] Y. Sugishita,et al. Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1? , 1997, Life sciences.
[2] D. Webb,et al. Endothelium-dependent modulation of responses to endothelin-I in human veins. , 1993, Clinical science.
[3] B. Löffler,et al. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). , 1994, Circulation.
[4] R. Nutt,et al. Identification of high affinity endothelin-1 receptor subtypes in human tissues. , 1991, Biochemical and biophysical research communications.
[5] M. J. Sumner,et al. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction , 1992, British journal of pharmacology.
[6] S. Nakanishi,et al. Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.
[7] D. Webb,et al. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1. , 1994, The Journal of clinical investigation.
[8] J. McMurray,et al. Fortnightly Review: Diagnosis and management of heart failure , 1994, BMJ.
[9] A. Davenport,et al. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. , 1993, Journal of cardiovascular pharmacology.
[10] R. Rodeheffer,et al. Increased plasma concentrations of endothelin in congestive heart failure in humans. , 1992, Mayo Clinic proceedings.
[11] J. Rouleau,et al. Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure. , 1998, Journal of cardiovascular pharmacology.
[12] A. Lerman,et al. Enhanced Coronary Vasoconstriction to Endothelin-BReceptor Activation in Experimental Congestive Heart Failure , 1996 .
[13] A. Lerman,et al. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. , 1996, Circulation.
[14] Y. Sugishita,et al. IS078 Expression of endothelin (ET)-1, ET_A, receptor, ET_B receptor, ET-converting enzyme and cellular distribution of ET-1 staining in the failing heart due to myocardial infarction in rats , 1998 .
[15] P. Vallance,et al. Endothelin receptors mediating functional responses in human small arteries and veins , 1994, British journal of pharmacology.
[16] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .
[17] W. H. Aellig. Clinical pharmacology, physiology and pathophysiology of superficial veins--2. , 1994, British journal of clinical pharmacology.
[18] K. Margulies,et al. Endothelin in experimental congestive heart failure in the anesthetized dog. , 1990, The American journal of physiology.
[19] J. McMurray,et al. Plasma Endothelin in Chronic Heart Failure , 1992, Circulation.
[20] M. Böhm,et al. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. , 1999, Circulation.
[21] Y. Sugishita,et al. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure , 1996, Nature.
[22] J. Vane,et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Binkley,et al. Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.
[24] D. Webb,et al. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. , 1996, Circulation.
[25] S. Goldman,et al. Importance of Venodilatation in Prevention of Left Ventricular Dilatation After Chronic Large Myocardial Infarction in Rats: A Comparison of Captopril and Hydralazine , 1989, Circulation research.
[26] T. Katsuya,et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure. , 1997, Circulation.
[27] D. Webb,et al. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. , 1995, Circulation.
[28] W. Waldhäusl,et al. Effect of endothelin-1 in man. , 1990, Circulation.
[29] W. H. Aellig. Clinical pharmacology, physiology and pathophysiology of superficial veins--1. , 1994, British journal of clinical pharmacology.
[30] W. H. Aellig. A new technique for recording compliance of human hand veins. , 1981, British journal of clinical pharmacology.
[31] P. Vanhoutte,et al. Endothelins 1 and 3 and big endothelin-1 contract isolated human placental veins. , 1993, Journal of cardiovascular pharmacology.
[32] A. Lerman,et al. Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.
[33] MichaelBöhm,et al. Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure , 1999 .
[34] D. Webb,et al. The pharmacology of human blood vessels in vivo. , 1995, Journal of vascular research.
[35] P. Hunziker,et al. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure , 1995, The Lancet.
[36] P. Binkley,et al. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure. , 1990, Circulation.
[37] Y. Sugishita,et al. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart. , 1999, The American journal of physiology.
[38] P. Vallance,et al. Human saphenous vein contains both endothelin ETA and ETB contractile receptors. , 1994, European journal of pharmacology.
[39] T. Sakurai,et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.